Dopaminergic regulation of glutamic acid decarboxylase mRNA expression and GABA release in the striatum: A review

[1]  M. Chesselet,et al.  Clozapine and haloperidol have differential effects on glutamic acid decarboxylase mRNA in the pallidal nuclei of the rat. , 1992, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology.

[2]  U. Ungerstedt,et al.  Amphetamine regulation of acetylcholine and γ-aminobutyric acid in nucleus accumbens , 1992, Neuroscience.

[3]  C. Gerfen.  The neostriatal mosaic: multiple levels of compartmental organization , 1992, Trends in Neurosciences.

[4]  M. Chesselet,et al.  Messenger RNAs encoding glutamate-decar☐ylases are differentially affected by nigrostriatal lesions in subpopulations of striatal neurons , 1992, Brain Research.

[5]  M. Chesselet,et al.  Distribution of glutamic acid decarboxylase (Mr 67 000) in the basal ganglia of the rat: an immunohistochemical study with a selective cDNA-generated polyclonal antibody , 1991, Journal of neurocytology.

[6]  D. Martin,et al.  Regulatory properties of brain glutamate decarboxylase (GAD): the apoenzyme of GAD is present principally as the smaller of two molecular forms of GAD in brain , 1991, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[7]  U. Ungerstedt,et al.  Short-term dopaminergic regulation of GABA release in dopamine deafferented caudate-putamen is not directly associated with glutamic acid decarboxylase gene expression , 1991, Neuroscience Letters.

[8]  M. Erlander,et al.  Two genes encode distinct glutamate decarboxylases , 1991, Neuron.

[9]  V. Notario,et al.  Transplants of fetal substantia nigra regulate glutamic acid decarboxylase gene expression in host striatal neurons. , 1991, Brain research. Molecular brain research.

[10]  C. Houser,et al.  Two Forms of the γ‐Aminobutyric Acid Synthetic Enzyme Glutamate Decarboxylase Have Distinct Intraneuronal Distributions and Cofactor Interactions , 1991, Journal of neurochemistry.

[11]  U. Ungerstedt,et al.  Regional specific effects of clozapine and haloperidol on GABA and dopamine release in rat basal ganglia. , 1990, European journal of pharmacology.

[12]  Allan J. Tobin,et al.  Parallel increases in striatal glutamic acid decarboxylase activity and mRNA levels in rats with lesions of the nigrostriatal pathway , 1990, Brain Research.

[13]  M. Delong,et al.  Primate models of movement disorders of basal ganglia origin , 1990, Trends in Neurosciences.

[14]  A. D. Smith,et al.  The neural network of the basal ganglia as revealed by the study of synaptic connections of identified neurones , 1990, Trends in Neurosciences.

[15]  U. Ungerstedt,et al.  The effects of intranigral GABA and dynorphin A injections on striatal dopamine and GABA release: Evidence that dopamine provides inhibitory regulation of striatal GABA neurons via D2 receptors , 1990, Brain Research.

[16]  N. Lindefors,et al.  Increased expression of glutamic acid decarboxylase mRNA in rat substantia nigra after an ibotenic acid lesion in the caudate-putamen. , 1990, Brain research. Molecular brain research.

[17]  J. Penney,et al.  The functional anatomy of basal ganglia disorders , 1989, Trends in Neurosciences.

[18]  M. Chesselet,et al.  Characterization of striatal neurons expressing high levels of glutamic acid decar☐ylase messenger RNA , 1989, Brain Research.

[19]  C. Feuerstein,et al.  Similar Time Course Changes in Striatal Levels of Glutamic Acid Decarboxylase and Proenkephalin mRNA Following Dopaminergic Deafferentation in the Rat , 1988, Journal of neurochemistry.

[20]  T. Joh,et al.  Gamma‐aminobutyric acid in the medial rat nucleus accumbens: Ultrastructural localization in neurons receiving monosynaptic input from catecholaminergic afferents , 1988, The Journal of comparative neurology.

[21]  H. Kita,et al.  Glutamate decarboxylase immunoreactive neurons in rat neostriatum: their morphological types and populations , 1988, Brain Research.

[22]  S. Paul,et al.  Glutamic acid decarboxylase mRNA in rat brain: regional distribution and effects of intrastriatal kainic acid. , 1987, Brain research.

[23]  M. Chesselet,et al.  Comparative distribution of mRNAs for glutamic acid decatrboxylase, tyrosine hydroxylase, and tachykinins in the basal ganglia: An in situ hybridization study in the rodent brain , 1987, The Journal of comparative neurology.

[24]  Y. Kubota,et al.  Dopaminergic axons directly make synapses with GABAergic neurons in the rat neostriatum , 1987, Brain Research.

[25]  J. Mallet,et al.  Molecular cloning, expression and in situ hybridization of rat brain glutamic acid decarboxylase messenger RNA , 1987, Neuroscience Letters.

[26]  T. Bonner,et al.  Mesencephalic dopamine neurons regulate the expression of neuropeptide mRNAs in the rat forebrain. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[27]  J. Girault,et al.  In vivo release of [3H]γ-aminobutyric acid in the rat neostriatum—II. Opposing effects of D1 and D2 dopamine receptor stimulation in the dorsal caudate putamen , 1986, Neuroscience.

[28]  M. Levine,et al.  The GABAergic striatonigral neurons of the cat: demonstration by double peroxidase labeling , 1986, Brain Research.

[29]  Y. Mizuno,et al.  Changes in γ-aminobutyrate, glutamate, aspartate, glycine, and taurine contents in the striatum after unilateral nigrostriatal lesions in rats , 1986, Experimental Neurology.

[30]  A. Scheibel,et al.  Biological substrates of schizophrenia , 1986, Acta neurologica Scandinavica.

[31]  J. Penney,et al.  γ‐Aminobutyric Acid and Benzodiazepine Receptor Changes Induced by Unilateral 6‐Hydroxydopamine Lesions of the Medial Forebrain Bundle , 1985, Journal of neurochemistry.

[32]  J. Wu,et al.  Glutamate decarboxylase‐immunoreactive structures in the rat neostriatum: A correlated light and electron microscopic study including a combination of Golgi impregnation with immunocytochemistry , 1985, The Journal of comparative neurology.

[33]  L. Gunne,et al.  Association with persistent neuroleptic-induced dyskinesia of regional changes in brain GABA synthesis , 1984, Nature.

[34]  U. Ungerstedt,et al.  Evidence that apomorphine and pergolide induce rotation in rats by different actions on D1 and D2 receptor sites. , 1984, European journal of pharmacology.

[35]  H. Fibiger,et al.  Striatal GABAergic Neuronal Activity Is Not Reduced in Parkinson's Disease , 1983, Journal of neurochemistry.

[36]  Y. Agid,et al.  Micro topography of Tyrosine Hydroxylase, Glutamic Acid Decarboxylase, and Choline Acetyltransferase in the Substantia Nigra and Ventral Tegmental Area of Control and Parkinsonian Brains , 1981, Journal of neurochemistry.

[37]  J. E. Vaughn,et al.  The GABA Neurons and their axon terminals in rat corpus striatum as demonstrated by GAD immunocytochemistry , 1979, The Journal of comparative neurology.

[38]  J. Walters,et al.  EFFECTS OF DEPOLARIZATION ON COFACTOR REGULATION OF GLUTAMIC ACID DECARBOXYLASE IN SUBSTANTIA NIGRA SYNAPTOSOMES , 1979, Journal of neurochemistry.

[39]  H. Fibiger,et al.  Increased striatal glutamate decarboxylase after lesions of the nigrostriatal pathway , 1978, Brain Research.

[40]  M. Brownstein,et al.  On the origin of substance P and glutamic acid decarboxylase (GAD) in the substantia nigra , 1977, Brain Research.

[41]  P. Mcgeer,et al.  Evidence for glutamic acid decarboxylase-containing interneurons in the neostriatum , 1975, Brain Research.

[42]  R. Lenox,et al.  REGIONAL γ‐AMINOBUTYRIC ACID LEVELS IN RAT BRAIN DETERMINED AFTER MICROWAVE FIXATION , 1975 .

[43]  C. Gerfen.  The neostriatal mosaic: multiple levels of compartmental organization in the basal ganglia. , 1992, Annual review of neuroscience.

[44]  J. Eccles,et al.  Inhibitory Amino Acid Neurotransmitters , 1987 .

[45]  O. Hornykiewicz.  Brain neurotransmitter changes in Parkinson's disease , 1981 .

[46]  M. Palkovits,et al.  Distribution of glutamate decarboxylase in discrete brain nuclei. , 1976, Brain research.